Year archive

RELIEF Therapeutics Holding AG — 2026 filings

All 8 regulatory filings released by RELIEF Therapeutics Holding AG (RLF) in 2026, sourced directly from the official regulator.

8 Filings

2026 Period

2026 filings (8)

Filing	Released	Lang
MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing Capital/Financing Update	2026-05-26	English
MindMaze Therapeutics and Vibra Healthcare Sign Definitive Channel Partnership Agreement to Scale Advanced Neurotherapeutics Across the U.S. Regulatory Filings	2026-05-12	English
MindMaze Therapeutics and Vibra Healthcare Announce Go-to-Market Partnership to Expand Commercial Footprint of Precision Neurotherapeutics in the U.S. Regulatory Filings	2026-04-30	English
MindMaze Therapeutics Publishes 2025 Annual Report and Corporate Update Report Publication Announcement	2026-04-15	English
MindMaze Therapeutics and Vibra Healthcare Announce Breakthrough RWE Results in High-Dose, High-Intensity Neurorehabilitation Regulatory Filings	2026-03-31	English
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank Regulatory Filings	2026-03-19	English
MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale Board/Management Information	2026-03-12	English
MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation Report Publication Announcement	2026-03-03	English